NeuroBo Pharmaceuticals Retained Earnings (Accumulated Deficit) 2015-2024 | NRBO

NeuroBo Pharmaceuticals retained earnings (accumulated deficit) from 2015 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

NeuroBo Pharmaceuticals Retained Earnings (Accumulated Deficit) 2015-2024 | NRBO

NeuroBo Pharmaceuticals retained earnings (accumulated deficit) from 2015 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.